annual EBIT:
$1.67B-$6.14B(-78.64%)Summary
- As of today (April 19, 2025), GILD annual earnings before interest & taxes is $1.67 billion, with the most recent change of -$6.14 billion (-78.64%) on December 31, 2024.
- During the last 3 years, GILD annual EBIT has fallen by -$7.61 billion (-82.03%).
- GILD annual EBIT is now -92.54% below its all-time high of $22.35 billion, reached on December 31, 2015.
Performance
GILD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$2.42B+$1.22B(+102.35%)Summary
- As of today (April 19, 2025), GILD quarterly earnings before interest & taxes is $2.42 billion, with the most recent change of +$1.22 billion (+102.35%) on December 31, 2024.
- Over the past year, GILD quarterly EBIT has increased by +$1.22 billion (+102.35%).
- GILD quarterly EBIT is now -57.37% below its all-time high of $5.67 billion, reached on December 31, 2015.
Performance
GILD quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$1.67B+$511.00M(+44.17%)Summary
- As of today (April 19, 2025), GILD TTM earnings before interest & taxes is $1.67 billion, with the most recent change of +$511.00 million (+44.17%) on December 31, 2024.
- Over the past year, GILD TTM EBIT has increased by +$511.00 million (+44.17%).
- GILD TTM EBIT is now -92.54% below its all-time high of $22.35 billion, reached on December 31, 2015.
Performance
GILD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GILD EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -78.6% | +102.3% | +44.2% |
3 y3 years | -82.0% | +102.3% | +44.2% |
5 y5 years | -72.9% | +102.3% | +44.2% |
GILD EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -82.0% | at low | -9.2% | +157.1% | -79.8% | +44.2% |
5 y | 5-year | -82.0% | at low | -34.5% | +157.1% | -83.9% | +312.9% |
alltime | all time | -92.5% | +1481.2% | -57.4% | +157.1% | -92.5% | +1482.1% |
Gilead Sciences EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $1.67B(-78.6%) | $2.42B(+102.3%) | $1.67B(+44.2%) |
Sep 2024 | - | $1.19B(-47.9%) | $1.16B(-54.0%) |
Jun 2024 | - | $2.29B(-154.1%) | $2.51B(+23.1%) |
Mar 2024 | - | -$4.23B(-322.2%) | $2.04B(-73.8%) |
Dec 2023 | $7.80B(+15.6%) | $1.91B(-25.3%) | $7.80B(-4.3%) |
Sep 2023 | - | $2.55B(+40.3%) | $8.15B(-1.3%) |
Jun 2023 | - | $1.82B(+18.8%) | $8.27B(+0.9%) |
Mar 2023 | - | $1.53B(-32.2%) | $8.19B(+21.4%) |
Dec 2022 | $6.75B(-27.3%) | $2.26B(-15.2%) | $6.75B(+23.0%) |
Sep 2022 | - | $2.66B(+52.5%) | $5.49B(-15.8%) |
Jun 2022 | - | $1.75B(+1929.1%) | $6.52B(-4.8%) |
Mar 2022 | - | $86.00M(-91.4%) | $6.84B(-26.2%) |
Dec 2021 | $9.28B(+249.8%) | $997.00M(-73.0%) | $9.28B(-10.5%) |
Sep 2021 | - | $3.69B(+77.9%) | $10.36B(+34.0%) |
Jun 2021 | - | $2.07B(-17.8%) | $7.74B(+164.0%) |
Mar 2021 | - | $2.52B(+21.1%) | $2.93B(+10.4%) |
Dec 2020 | $2.65B(-56.9%) | $2.08B(+96.1%) | $2.65B(-2.3%) |
Sep 2020 | - | $1.06B(-138.8%) | $2.72B(+572.3%) |
Jun 2020 | - | -$2.73B(-221.8%) | $404.00M(-93.0%) |
Mar 2020 | - | $2.24B(+4.7%) | $5.79B(-5.8%) |
Dec 2019 | $6.16B(-30.7%) | $2.14B(-271.4%) | $6.16B(+16.5%) |
Sep 2019 | - | -$1.25B(-147.1%) | $5.28B(-44.2%) |
Jun 2019 | - | $2.66B(+2.1%) | $9.46B(+3.3%) |
Mar 2019 | - | $2.60B(+104.6%) | $9.16B(+3.2%) |
Dec 2018 | $8.88B(-39.4%) | $1.27B(-56.5%) | $8.88B(-11.5%) |
Sep 2018 | - | $2.93B(+24.5%) | $10.03B(-9.3%) |
Jun 2018 | - | $2.35B(+1.2%) | $11.06B(-15.5%) |
Mar 2018 | - | $2.32B(-4.1%) | $13.09B(-10.6%) |
Dec 2017 | $14.65B(-18.9%) | $2.42B(-38.8%) | $14.65B(-10.7%) |
Sep 2017 | - | $3.96B(-9.6%) | $16.41B(-3.3%) |
Jun 2017 | - | $4.38B(+13.0%) | $16.96B(-1.4%) |
Mar 2017 | - | $3.88B(-7.3%) | $17.21B(-4.7%) |
Dec 2016 | $18.06B(-19.2%) | $4.18B(-7.4%) | $18.06B(-7.6%) |
Sep 2016 | - | $4.52B(-2.3%) | $19.54B(-5.4%) |
Jun 2016 | - | $4.63B(-2.2%) | $20.66B(-4.7%) |
Mar 2016 | - | $4.73B(-16.5%) | $21.69B(-3.0%) |
Dec 2015 | $22.35B(+46.4%) | $5.67B(+0.5%) | $22.35B(+6.2%) |
Sep 2015 | - | $5.64B(-0.2%) | $21.04B(+11.5%) |
Jun 2015 | - | $5.65B(+4.8%) | $18.88B(+7.0%) |
Mar 2015 | - | $5.39B(+23.7%) | $17.64B(+15.5%) |
Dec 2014 | $15.27B(+238.2%) | $4.36B(+25.5%) | $15.27B(+26.2%) |
Sep 2014 | - | $3.48B(-21.2%) | $12.09B(+23.8%) |
Jun 2014 | - | $4.41B(+45.7%) | $9.77B(+49.9%) |
Mar 2014 | - | $3.02B(+155.1%) | $6.52B(+44.4%) |
Dec 2013 | $4.51B(+13.6%) | $1.19B(+2.8%) | $4.51B(+1.7%) |
Sep 2013 | - | $1.15B(+0.0%) | $4.44B(+2.6%) |
Jun 2013 | - | $1.15B(+12.9%) | $4.32B(+2.3%) |
Mar 2013 | - | $1.02B(-7.8%) | $4.23B(+6.4%) |
Dec 2012 | $3.97B(+3.0%) | $1.11B(+6.5%) | $3.97B(+5.7%) |
Sep 2012 | - | $1.04B(-1.7%) | $3.76B(+0.6%) |
Jun 2012 | - | $1.06B(+38.1%) | $3.74B(+0.8%) |
Mar 2012 | - | $766.10M(-14.3%) | $3.71B(-3.9%) |
Dec 2011 | $3.86B(-4.1%) | $893.84M(-12.2%) | $3.86B(+1.4%) |
Sep 2011 | - | $1.02B(-1.0%) | $3.80B(+0.6%) |
Jun 2011 | - | $1.03B(+12.3%) | $3.78B(+0.5%) |
Mar 2011 | - | $915.80M(+9.0%) | $3.76B(-6.5%) |
Dec 2010 | $4.02B(+12.6%) | $840.14M(-15.5%) | $4.02B(-5.6%) |
Sep 2010 | - | $994.67M(-1.6%) | $4.26B(+2.1%) |
Jun 2010 | - | $1.01B(-14.1%) | $4.17B(+6.0%) |
Mar 2010 | - | $1.18B(+9.3%) | $3.94B(+10.2%) |
Dec 2009 | $3.57B(+30.4%) | $1.08B(+18.5%) | $3.57B(+9.7%) |
Sep 2009 | - | $908.42M(+17.4%) | $3.25B(+7.1%) |
Jun 2009 | - | $773.98M(-4.7%) | $3.04B(+5.4%) |
Mar 2009 | - | $812.47M(+6.9%) | $2.89B(+4.4%) |
Dec 2008 | $2.74B(+26.5%) | $759.70M(+9.5%) | $2.76B(+9.7%) |
Sep 2008 | - | $693.83M(+12.0%) | $2.52B(+6.2%) |
Jun 2008 | - | $619.54M(-10.3%) | $2.37B(+3.3%) |
Mar 2008 | - | $690.75M(+34.3%) | $2.30B(+6.0%) |
Dec 2007 | $2.16B | $514.49M(-5.9%) | $2.16B(+1.4%) |
Sep 2007 | - | $547.03M(+0.8%) | $2.14B(+6.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2007 | - | $542.85M(-3.1%) | $2.00B(+9.7%) |
Mar 2007 | - | $560.14M(+15.4%) | $1.82B(+11.5%) |
Dec 2006 | $1.64B(+47.4%) | $485.22M(+17.5%) | $1.64B(+8.3%) |
Sep 2006 | - | $413.11M(+13.1%) | $1.51B(+12.3%) |
Jun 2006 | - | $365.31M(-1.7%) | $1.35B(+7.0%) |
Mar 2006 | - | $371.65M(+3.3%) | $1.26B(+13.4%) |
Dec 2005 | $1.11B(+76.8%) | $359.84M(+45.0%) | $1.11B(+21.8%) |
Sep 2005 | - | $248.25M(-10.5%) | $910.22M(+10.2%) |
Jun 2005 | - | $277.50M(+24.2%) | $825.74M(+16.9%) |
Mar 2005 | - | $223.48M(+38.8%) | $706.44M(+12.6%) |
Dec 2004 | $627.39M(+90.2%) | $161.00M(-1.7%) | $627.39M(+13.2%) |
Sep 2004 | - | $163.77M(+3.5%) | $554.37M(+18.0%) |
Jun 2004 | - | $158.20M(+9.5%) | $469.77M(+12.0%) |
Mar 2004 | - | $144.42M(+64.2%) | $419.35M(+27.1%) |
Dec 2003 | $329.92M(+307.3%) | $87.98M(+11.1%) | $329.92M(+20.1%) |
Sep 2003 | - | $79.17M(-26.5%) | $274.79M(+18.7%) |
Jun 2003 | - | $107.77M(+95.9%) | $231.53M(+62.0%) |
Mar 2003 | - | $55.00M(+67.5%) | $142.95M(+76.5%) |
Dec 2002 | $81.01M(-167.1%) | $32.84M(-8.6%) | $81.01M(+248.5%) |
Sep 2002 | - | $35.92M(+87.1%) | $23.24M(-147.7%) |
Jun 2002 | - | $19.19M(-376.5%) | -$48.74M(-52.1%) |
Mar 2002 | - | -$6.94M(-72.1%) | -$101.83M(-15.6%) |
Dec 2001 | -$120.69M(+130.7%) | -$24.92M(-30.9%) | -$120.69M(+5.5%) |
Sep 2001 | - | -$36.07M(+6.4%) | -$114.42M(+15.2%) |
Jun 2001 | - | -$33.90M(+31.4%) | -$99.29M(+39.8%) |
Mar 2001 | - | -$25.80M(+38.3%) | -$71.03M(+43.0%) |
Dec 2000 | -$52.32M(+1.2%) | -$18.65M(-10.9%) | -$49.68M(+119.5%) |
Sep 2000 | - | -$20.94M(+271.6%) | -$22.63M(-31.2%) |
Jun 2000 | - | -$5.63M(+26.6%) | -$32.89M(-17.0%) |
Mar 2000 | - | -$4.45M(-153.0%) | -$39.62M(-23.4%) |
Dec 1999 | -$51.70M(-34.0%) | $8.40M(-126.9%) | -$51.72M(-36.2%) |
Sep 1999 | - | -$31.20M(+152.4%) | -$81.02M(+13.4%) |
Jun 1999 | - | -$12.36M(-25.3%) | -$71.42M(-9.4%) |
Mar 1999 | - | -$16.55M(-20.8%) | -$78.85M(+5.8%) |
Dec 1998 | -$78.30M(+8.6%) | -$20.90M(-3.2%) | -$74.50M(-23.4%) |
Sep 1998 | - | -$21.60M(+9.1%) | -$97.20M(+7.2%) |
Jun 1998 | - | -$19.80M(+62.3%) | -$90.70M(+25.4%) |
Mar 1998 | - | -$12.20M(-72.0%) | -$72.30M(+0.4%) |
Dec 1997 | -$72.10M(+99.7%) | -$43.60M(+188.7%) | -$72.00M(+76.9%) |
Sep 1997 | - | -$15.10M(+978.6%) | -$40.70M(+102.5%) |
Jun 1997 | - | -$1.40M(-88.2%) | -$20.10M(-41.9%) |
Mar 1997 | - | -$11.90M(-3.3%) | -$34.60M(-3.9%) |
Dec 1996 | -$36.10M(+12.8%) | -$12.30M(-323.6%) | -$36.00M(+51.9%) |
Sep 1996 | - | $5.50M(-134.6%) | -$23.70M(-39.4%) |
Jun 1996 | - | -$15.90M(+19.5%) | -$39.10M(+21.4%) |
Mar 1996 | - | -$13.30M(+34.3%) | -$32.20M(-15.5%) |
Dec 1995 | -$32.00M(-9.1%) | - | - |
Sep 1995 | - | -$9.90M(+10.0%) | -$38.10M(+5.5%) |
Jun 1995 | - | -$9.00M(-10.0%) | -$36.10M(+2.6%) |
Mar 1995 | - | -$10.00M(+8.7%) | -$35.20M(+2.6%) |
Mar 1995 | -$35.20M(+19.3%) | - | - |
Dec 1994 | - | -$9.20M(+16.5%) | -$34.30M(+4.9%) |
Sep 1994 | - | -$7.90M(-2.5%) | -$32.70M(+3.5%) |
Jun 1994 | - | -$8.10M(-11.0%) | -$31.60M(+7.8%) |
Mar 1994 | -$29.50M(+62.1%) | -$9.10M(+19.7%) | -$29.30M(+8.1%) |
Dec 1993 | - | -$7.60M(+11.8%) | -$27.10M(+11.5%) |
Sep 1993 | - | -$6.80M(+17.2%) | -$24.30M(+14.6%) |
Jun 1993 | - | -$5.80M(-15.9%) | -$21.20M(+16.5%) |
Mar 1993 | -$18.20M(+188.9%) | -$6.90M(+43.8%) | -$18.20M(-1.6%) |
Dec 1992 | - | -$4.80M(+29.7%) | -$18.50M(+40.2%) |
Sep 1992 | - | -$3.70M(+32.1%) | -$13.20M(+41.9%) |
Jun 1992 | - | -$2.80M(-61.1%) | -$9.30M(+47.6%) |
Mar 1992 | -$6.30M(+31.3%) | -$7.20M(-1540.0%) | -$6.30M(+57.5%) |
Dec 1991 | - | $500.00K(+150.0%) | -$4.00M(-9.1%) |
Sep 1991 | - | $200.00K(0.0%) | -$4.40M(-2.2%) |
Jun 1991 | - | $200.00K(-104.1%) | -$4.50M(-2.2%) |
Mar 1991 | -$4.80M | -$4.90M(-5000.0%) | -$4.60M(-1633.3%) |
Dec 1990 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
Sep 1990 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
Jun 1990 | - | $100.00K | $100.00K |
FAQ
- What is Gilead Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Gilead Sciences?
- What is Gilead Sciences annual EBIT year-on-year change?
- What is Gilead Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Gilead Sciences?
- What is Gilead Sciences quarterly EBIT year-on-year change?
- What is Gilead Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Gilead Sciences?
- What is Gilead Sciences TTM EBIT year-on-year change?
What is Gilead Sciences annual earnings before interest & taxes?
The current annual EBIT of GILD is $1.67B
What is the all time high annual EBIT for Gilead Sciences?
Gilead Sciences all-time high annual earnings before interest & taxes is $22.35B
What is Gilead Sciences annual EBIT year-on-year change?
Over the past year, GILD annual earnings before interest & taxes has changed by -$6.14B (-78.64%)
What is Gilead Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of GILD is $2.42B
What is the all time high quarterly EBIT for Gilead Sciences?
Gilead Sciences all-time high quarterly earnings before interest & taxes is $5.67B
What is Gilead Sciences quarterly EBIT year-on-year change?
Over the past year, GILD quarterly earnings before interest & taxes has changed by +$1.22B (+102.35%)
What is Gilead Sciences TTM earnings before interest & taxes?
The current TTM EBIT of GILD is $1.67B
What is the all time high TTM EBIT for Gilead Sciences?
Gilead Sciences all-time high TTM earnings before interest & taxes is $22.35B
What is Gilead Sciences TTM EBIT year-on-year change?
Over the past year, GILD TTM earnings before interest & taxes has changed by +$511.00M (+44.17%)